Last edition
News about "Maharashtra FDA"
Maharashtra FDA Conducts 2,902 Inspections, Acts Against 880 Drug Licence Holders
Maharashtra FDA’s intensified inspections identified compliance gaps across pharmaceutical manufacturing, sales, blood centres and storage facilities.
Maharashtra FDA | 08/09/2026 | By News Bureau
Maharashtra FDA Cancels Cipla Pharma's C&F Drug Licences in Pune Over Regulatory Violations
Maharashtra FDA has cancelled Cipla Pharma & Life Sciences’ C&F drug sale and distribution licences at Vadki, Pune, citing violations linked to misbranded ‘Reactin Plus’ tablets, storage deficiencies, inventory discrepancies and non-compliance with recall directions.
Maharashtra FDA | 31/08/2026 | By News Bureau | 113
Maharashtra FDA Warns Drug Applicants Against Unauthorised Agents, Intermediaries
Maharashtra FDA has warned drug manufacturers, wholesalers and retailers against unauthorised agents demanding money for licences and urged applicants to use the official online system directly.
Maharashtra FDA | 14/08/2026 | By News Bureau | 109
The deadline for voluntary registration of Class A and Class B medical devices with the regulator ended on September 30, 2021 and registration became compulsory from October 1, 2021. Manufacturers are required to complete mandatory registration with the CDSCO by September 30, 2022. It has come to the notice that a significant number
Maharashtra FDA | 16/02/2022 | By Darshana | 704
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy